Isocitrate dehydrogenase (IDH) inhibitors market size are expected to reach US$ 39.16 billion in 2033, growing at a compound annual growth rate (CAGR) of 33% from 2023 to 2033, from a market size of US$ 1.7 billion in 2022. Additionally, the development of more potent and selective IDH inhibitors, as well as the expansion …